innoscripta SE (FRA:1INN)
| Market Cap | 494.00M -53.7% |
| Revenue (ttm) | 122.41M +42.5% |
| Net Income | 51.28M +51.1% |
| EPS | 5.13 +51.1% |
| Shares Out | n/a |
| PE Ratio | 9.60 |
| Forward PE | 8.98 |
| Dividend | 4.00 (8.13%) |
| Ex-Dividend Date | Apr 22, 2026 |
| Volume | 334 |
| Open | 49.20 |
| Previous Close | 50.00 |
| Day's Range | 48.00 - 49.20 |
| 52-Week Range | 31.90 - 128.60 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 3, 2026 |
About innoscripta SE
innoscripta SE provides software-as-a-service for managing research and development (R&D) tax incentives and project management consulting in European markets, including Germany, France, Romania, Denmark, Finland, Switzerland, Spain, Portugal, Slovakia, the Netherlands, and the United Kingdom. It offers Clusterix, a scalable software platform for the structured organization and management of research and development activities. Companies use Clusterix to efficiently manage innovation projects, digitize internal processes, and make their R&D act... [Read more]
Financial Performance
In 2025, innoscripta SE's revenue was 103.41 million, an increase of 59.82% compared to the previous year's 64.71 million. Earnings were 42.61 million, an increase of 69.82%.
Financial StatementsNews
EQS-Adhoc: innoscripta SE: Searches at innoscripta Group entities in connection with investigations relating to research allowances
EQS-Ad-hoc: innoscripta SE / Key word(s): Other innoscripta SE: Searches at innoscripta Group entities in connection with investigations relating to research allowances 01-Oct-2026 / 13:52 CET/CEST Di...
innoscripta SE Earnings Call Transcript: Q2 2026
Revenue grew 43% year-over-year in H1 2026 to EUR 63 million, with EBIT up 49% to EUR 36.4 million. System migration temporarily impacted Q2, but guidance for EUR 140 million revenue and EUR 80 million EBIT is confirmed. International expansion and improved cash collection support long-term growth.
innoscripta SE Slides: Q2 2026
innoscripta SE has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 25, 2026.
innoscripta SE Quarterly report: Q2 2026
innoscripta SE has published its Q2 2026 quarterly earnings report on August 25, 2026.
innoscripta SE Quarterly report: Q1 2026
innoscripta SE has published its Q1 2026 quarterly earnings report on May 26, 2026.
innoscripta SE Slides: Q1 2026
innoscripta SE has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 26, 2026.
innoscripta SE Annual report: Q4 2025
innoscripta SE has published its Q4 2025 annual report on March 20, 2026.
innoscripta SE Annual report: Q4 2025
innoscripta SE has published its Q4 2025 annual report on March 20, 2026.
innoscripta SE Earnings Call Transcript: Q4 2025
Revenue and EBIT surged nearly 60% year-over-year, driven by enterprise client wins and product innovation. Management expects continued high growth and margins, supported by regulatory tailwinds and international expansion, with a focus on shareholder returns.
innoscripta SE Earnings release: Q4 2025
innoscripta SE released its Q4 2025 earnings on February 3, 2026, summarizing the period's financial results.
innoscripta SE Slides: Q4 2025
innoscripta SE has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 3, 2026.
innoscripta SE Quarterly report: Q3 2025
innoscripta SE has published its Q3 2025 quarterly earnings report on November 3, 2025.
innoscripta SE Slides: Q3 2025
innoscripta SE has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 3, 2025.